One pill to stop breast pain after pregnancy loss: new study shows promise
NCT ID NCT06029673
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 33 times
Summary
This study tested whether a single dose of cabergoline can prevent breast pain, engorgement, and milk leakage in people who had an abortion or pregnancy loss between 16 and 20 weeks. 69 participants were randomly assigned to receive cabergoline or a placebo. The goal was to see if the drug could reduce physical and emotional distress from breast symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LACTATION SUPPRESSED are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Planned Parenthood - San Jose Central Health Center
San Jose, California, 95126, United States
-
Stanford University
Stanford, California, 94305, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.